KLRS Q3 2020 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$18,000

Operating Income

-$24M

Net Income

-$24M

EPS (Diluted)

$-13.42

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$394M

Total Liabilities

$20M

Stockholders' Equity

$374M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$18,000	$0	—
Operating Income	-$24M	-$8M	-181.9%
Net Income	-$24M	-$7M	-224.8%